Cypherpunk Technologies Inc. (CYPH)
NASDAQ:CYPH
Want to see CYPH full AI Analyst Report?
Top Page
Cypherpunk Technologies
(NASDAQ:CYPH)
Select Model
Select Model
Rating:45Neutral
Price Target:
$1.00
Action:Reiterated
Date:05/21/26
The score is primarily weighed down by weak financial performance (large losses and significant ongoing cash burn despite low debt) and additional listing-risk from the Nasdaq minimum bid notice. Technical indicators are comparatively supportive (price above key moving averages with positive MACD), but they are not strong enough to offset the fundamental and compliance risks, and valuation is constrained by a negative P/E and no dividend yield.
Positive Factors
Low leverage / strong liquidity flexibility
Very low reported debt gives the company enduring financial flexibility versus highly leveraged peers. Over the next several months this reduces bankruptcy and refinancing risk, enabling management to pursue product development or strategic options without immediate pressure from creditors.
Negative Factors
Severe cash burn
Sustained, large negative operating and free cash flow shows the business is not self-funding and will likely need external capital. Over the next 2–6 months this raises dilution and execution risk, constraining investment in product scaling and forcing reprioritization of initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong liquidity flexibility
Very low reported debt gives the company enduring financial flexibility versus highly leveraged peers. Over the next several months this reduces bankruptcy and refinancing risk, enabling management to pursue product development or strategic options without immediate pressure from creditors.
Read all positive factors
Cypherpunk Technologies (CYPH) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$127.76M
Dividend YieldN/A
Average Volume (3M)3.80M
Price to Earnings (P/E)―
Beta (1Y)0.83
Revenue GrowthN/A
EPS Growth99.27%
CountryUS
Employees52
SectorFinancial
Sector Strength70
IndustryBiotechnology
Share Statistics
EPS (TTM)-0.02
Shares Outstanding106,464,485
10 Day Avg. Volume4,111,729
30 Day Avg. Volume3,795,621
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)0.50
Price to Sales (P/S)0.00
P/FCF Ratio-1.75
Enterprise Value/Market Cap0.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-2.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.15
Revenue Forecast (FY)N/A
Cypherpunk Technologies Business Overview & Revenue Model
Company Description
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1...
How the Company Makes Money
null...
Cypherpunk Technologies Financial Statement Overview
Summary
Income Statement
9
Very Negative
Balance Sheet
55
Neutral
Cash Flow
8
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.50M |
| Gross Profit | 0.00 | 0.00 | 0.00 | -427.00K | 0.00 | 1.50M |
| EBITDA | -29.65M | -36.54M | -70.05M | -80.99M | -54.38M | -40.54M |
| Net Income | -56.91M | 4.82M | -67.56M | -81.41M | -54.60M | -40.59M |
Balance Sheet | ||||||
| Total Assets | 87.38M | 163.18M | 49.12M | 72.83M | 58.09M | 117.91M |
| Cash, Cash Equivalents and Short-Term Investments | 6.69M | 14.04M | 47.25M | 70.64M | 43.76M | 114.92M |
| Total Debt | 38.00K | 38.00K | 266.00K | 262.00K | 524.00K | 469.00K |
| Total Liabilities | 3.00M | 9.68M | 14.08M | 12.68M | 3.45M | 10.02M |
| Stockholders Equity | 84.38M | 153.51M | 35.05M | 60.14M | 54.64M | 107.89M |
Cash Flow | ||||||
| Free Cash Flow | -42.82M | -43.90M | -60.30M | -43.75M | -49.04M | -35.16M |
| Operating Cash Flow | -40.83M | -43.90M | -60.30M | -43.75M | -49.04M | -35.16M |
| Investing Cash Flow | -92.01M | -97.00M | 0.00 | 48.97M | 0.00 | 0.00 |
| Financing Cash Flow | 113.12M | 107.65M | 37.18M | -30.00K | -210.00K | 98.03M |
Cypherpunk Technologies Technical Analysis
―
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CYPH, the sentiment is undefined. The current price of undefined is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a undefined sentiment for CYPH.
Cypherpunk Technologies Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
* Financial Sector Average
Performance Comparison
Cypherpunk Technologies Corporate Events
Executive/Board Changes
Cypherpunk Technologies Announces Planned Board Leadership Transitions
Neutral
Apr 10, 2026
On April 7, 2026, Cypherpunk Technologies said Class III directors Dr. Christopher Mirabelli and Dr. Joseph Loscalzo notified the company of their plans to retire from the Board and not stand for re‑election at the 2026 Annual Meeting, submi...
Delistings and Listing ChangesRegulatory Filings and Compliance
Cypherpunk Technologies Receives Nasdaq Minimum Bid Price Notice
Negative
Mar 9, 2026
On March 4, 2026, Cypherpunk Technologies Inc. disclosed that it received a Nasdaq notice stating its common stock had closed below the $1.00 minimum bid price requirement for the past 30 consecutive business days, triggering a deficiency under Na...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.